 Horizon Therapeutics Public Limited Company NASDAQ:HZNP Q3 2022 Results Conference Call November 2, 2022 8:00 AM ET Company Participants Tina Ventura - Senior Vice President, Chief Investor Relations Officer Tim Walbert - Chairman, President and Chief Executive Officer Liz Thompson - Executive Vice President, Research Development Aaron Cox - Executive Vice President and Chief Financial Officer Andy Pasternak - Executive Vice President, Chief Strategy Officer Conference Call Participants Chris Schott - JPMorgan Annabel Samimy - Stifel Madhu Kumar - Goldman Sachs Jason Gerberry - Bank of America Ken Cacciatore - Cowen David Risinger - SVB Securities LLC David Amsellem - Piper Sandler Gary Nachman - BMO Capital Markets Equity Research Amy Li - Jefferies Operator Good morning, and thank you for standing by. Welcome to the Horizon Therapeutics plc Third Quarter 2022 Earnings Conference Call. 